Prostate cancer: management of advanced disease

Ann Oncol. 2002:13 Suppl 4:89-94. doi: 10.1093/annonc/mdf644.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Androgen Antagonists / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Biopsy, Needle
  • Brachytherapy / methods*
  • Combined Modality Therapy / methods
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness / pathology*
  • Neoplasm Staging
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy*
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Survival Rate
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Prostate-Specific Antigen